mainly pressure areas in the palms and soles. The heart manifestations appear during the teenage years and are severe and progressive and may end with arrhythmia and premature sudden death.
The disease was originally described in individuals from the Greek Island Naxos by Protonotarios et al in 1986 and byBarker et alin 1998. In 1998, Carvajal-Huerta reported patients from Guayaquil, Ecuador with a similar autosomal recessive triad, with combined epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy, and described the skin manifestations.
Another family with the autosomal dominant association of nonepidermolytic palmoplantar keratoderma, woolly hair, and dilated right ventricle was reported by Tosti et al (1994) in an Italian family. Recently, Coonar et al (1998) mapped the gene for the Greek families (Naxos disease) to 17q21, and a mutation in the plakoglobin gene was identified as responsible for the disease in the Greek families (McKoy et al, 2000) . In the Ecuadorian family, a mutation in the desmoplakin gene was found to be responsible for the disease (Norgett et al, 2000) . In this study, we report the clinical findings in two new Arab families with Naxos disease originating from villages near Jerusalem. Importantly, we have excluded both plakoglobin and desmoplakin as the candidate genes in these families. Furthermore, we have analyzed several other regions harboring candidate genes of interest, and found no evidence for linkage.
The pedigree structures of the two families are shown in Figure 1(a, b) . The history and clinical examination of patients from families A and B included the congenital appearance of woolly, curly, rough, light colored scalp hair with sparse eyebrows, axillary, and pubic hair (Figure 1c Since all the affected members descended from consanguineous couples, we hypothesized that the impaired gene must have arisen from the same ancestral mutation in both alleles. Thus, heterozygosity for the candidate gene/region was considered sufficient for exclusion of genetic linkage. Although both families originated from the same geographic region in Israel, suggesting they might be related, we elected to evaluate each candidate locus allowing for genetic heterogeneity. First, we screened for mutations in the human desmoplakin (NM_004415) and plakoglobin (AJ249711) genes (Franke et al, 1989; Virata et al, 1992) . Sequence analysis of each exon and splice junctions of the desmoplakin and plakoglobin genes (Whittock et al, 1999 (Whittock et al, ,2000 from affected individuals revealed no mutation in both genes compared with unrelated unaffected individuals. Furthermore, we identified several heterozygous sequence changes in the introns of affected individuals, supporting the exclusion of these genes (data not shown).
Second, on the basis of the role of both desmoplakin and plakoglobin in cell adhesion, several other genes coding for components of the desmosomes or proteins involved in different aspects of cell adhesion were considered as candidate genes for the disease in our families. These included the genes coding for type I and type II keratins on chromosomes 17 and 12, respectively (Romano et al, 1988; Yoon et al, 1994; Aberle et al, 1995; Coonar et al, 1998) , desmoyokin on 11q13.1 (Courseaux et al, 1996) , and the desmocollin/ desmoglein cluster on 18q12.1 (Arnemann et al, 1991) . We also analyzed markers for plakophilin 1 at 1q32 (Cowley et al, 1997) , plakophilin 2 at 12p13 (Bonne et al, 1998) , and plakophilin 4 (or p0071) at 2q23-q31 (Hatzfeld and Nachtsheim, 1996; Bonne et al, 1998). As the gene structures were not available for each of these genes, we performed cosegregation and homozygosity studies using microsatellite markers covering these loci ( Table I) . As a result, none of the regions analyzed showed cosegregation with the disease trait.
Moreover, heterozygosity in the affected members could be used to exclude the regions on chromosomes 12, 17, and 18, harboring the keratins and desmocollin/desmoglein gene clusters, respectively, as well as for the chromosomal regions containing plakophilin 1, 2, and 4 as specified in Table I .
These findings emphasize the hetergeneous genetic basis of Naxos disease, which appears to segregate in a dominant manner as well as the autosomal recessive forms (Tosti et al, 1994) . Our future work will be directed toward the evaluation of additional desmosomal proteins, as well as conducting a whole genome scan to find regions homozygous by descent, and identify a novel causative gene(s) underlying Naxos disease. 
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